PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Knowledge and worry following review of standard vs patient-centered pathology reports

JAMA

2025-01-02
(Press-News.org)

About The Study: Most study participants could not extract basic information—including whether they have cancer—from standard prostate cancer pathology reports but were able to understand this diagnostic information from the patient-centered pathology reports (PCPRs). Also, they discriminated between risk levels (i.e., lower levels of perceived worry in the low-risk condition) with PCPRs compared with standard reports. Hospital systems should consider including PCPRs with standard pathology reports to improve patient understanding. 

Corresponding Author: To contact the corresponding author, Cathryn J. Lapedis, MD, MPH, MS, email cathrynb@med.umich.edu.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jama.2024.25461)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.25461?guestAccessKey=750b4a2a-5207-46ca-b9c1-a6e27b0df59b&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=010225

 

END



ELSE PRESS RELEASES FROM THIS DATE:

Cardiovascular disease and breast cancer stage at diagnosis

2025-01-02
About The Study: This case-control study found that individuals with more advanced breast cancer at diagnosis were more likely to have prevalent cardiovascular disease. This finding may be specific to hormone receptor–positive and ERBB2-negative (formerly HER2) disease. Future studies are needed to confirm these findings and investigate interventions to improve patient outcomes, including personalized cancer screening. Corresponding Author: To contact the corresponding author, Kevin T. Nead, MD, MPhil, email ktnead@mdanderson.org. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2024.52890) Editor’s ...

Herpes virus might drive Alzheimer's pathology, study suggests

Herpes virus might drive Alzheimers pathology, study suggests
2025-01-02
PITTSBURGH, Jan. 2, 2025 – University of Pittsburgh researchers uncovered a surprising link between Alzheimer’s disease and herpes simplex virus-1 (HSV-1), suggesting that viral infections may play a role in the disease. The study results are published today in Cell Reports. The study also revealed how tau protein, often viewed as harmful in Alzheimer’s, might initially protect the brain from the virus but contribute to brain damage later. These findings could lead to new treatments targeting infections and the brain’s immune response. “Our study challenges ...

Patients with heart disease may be at increased risk for advanced breast cancer

Patients with heart disease may be at increased risk for advanced breast cancer
2025-01-02
HOUSTON ― Cardiovascular disease (CVD) and cancer are the two leading causes of death in the U.S. According to researchers from The University of Texas MD Anderson Cancer Center, patients diagnosed with late-stage or metastatic breast cancer have a statistically significant increased risk of pre-diagnosis CVD compared to those with early-stage cancer at diagnosis. The study, published today in JAMA Network Open, found those with advanced breast cancer at diagnosis were 10% more likely to have had pre-existing ...

Chinese Medical Journal study reveals potential use of artificial intelligence (AI) in finding new glaucoma drugs

Chinese Medical Journal study reveals potential use of artificial intelligence (AI) in finding new glaucoma drugs
2025-01-02
Glaucoma is a progressive eye disorder characterized by fluid buildup inside the eye, causing ocular hypertension. By 2040, it is estimated that 111.8 million people worldwide will be affected by glaucoma, potentially leading to blindness if left untreated. Currently, there are treatments available to manage ocular hypertension, but a cure for glaucoma remains elusive. Retinal ganglion cells (RGCs) are crucial for transmitting visual signals from the eyes to the brain, and their degeneration leads to optic nerve damage, which is a hallmark of glaucoma.  In recent years, scientists ...

Genomic analysis of modern maize inbred lines reveals diversity and selective breeding effects

Genomic analysis of modern maize inbred lines reveals diversity and selective breeding effects
2025-01-02
Maize is a globally cultivated staple crop and one of the most successful examples of heterosis utilization in food production. The development of elite inbred lines is critical for breeding hybrid varieties and achieving sustained yield improvements. However, efficient breeding of inbred lines faces significant challenges, including the broad origins of germplasm resources, complex and diverse genetic structures, and low accuracy in phenotypic prediction. Advances in modern genomics and artificial intelligence technologies ...

Research alert: Enzyme promoting tumor growth and spread in pancreatic cancer identified

2025-01-02
Pancreatic cancer kills 50,000 people each year, according to the National Cancer Institute, and there are few effective treatment options for the disease. In a new study, researchers at University of California San Diego School of Medicine have discovered that an enzyme called MICAL2 promotes tumor growth and spread in pancreatic ductal adenocarcinomas (PDAC), the most common form of pancreatic cancer. The study will be published on January 2, 2025 in Cancer Research, a journal of the American Association for Cancer Research. Normally, MICAL2 plays an important role in cell migration and morphology. But when the researchers measured ...

NIH officials assess threat of H5N1

NIH officials assess threat of H5N1
2025-01-02
WHAT: Highly pathogenic H5N1 avian influenza A virus (HPAI H5N1) remains a low risk to the general public, and public health experts in the United States believe that available treatments and vaccines, as well as those in development, are sufficient to prevent severe disease. However, the National Institutes of Health (NIH) and its federal partners remain focused on monitoring the virus and evaluating changes, according to leading officials at the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH.  In a commentary published in the New England Journal of Medicine, NIAID Director Jeanne M. Marrazzo, M.D., M.P.H., and Michael G. Ison, M.D., M.S., chief ...

Study finds physical activity reduces chronic disease risk

Study finds physical activity reduces chronic disease risk
2025-01-02
University of Iowa researchers are recommending all patients be surveyed about their physical activity levels, after a new study underscores the link between physical activity and chronic disease. The study, led by Lucas Carr, associate professor in the Department of Health and Human Physiology, examined responses from more than 7,000 patients at University of Iowa Health Care Medical Center who noted their level of physical activity in a questionnaire.  From patients’ answers to the questionnaire, the researchers found that those who reported the highest level of physical activity — meaning they exercised moderately ...

Based on AI-powered De novo Generation, Insilico Medicine nominates ISM1745 as preclinical candidate targeting PRMT5

Based on AI-powered De novo Generation, Insilico Medicine nominates ISM1745 as preclinical candidate targeting PRMT5
2025-01-02
Since 2021, Insilico Medicine has successfully nominated 22 preclinical candidates (PCCs) with the help of its proprietary Pharma.AI platform, among which 5 were nominated just the year of 2024. The novel scaffold of ISM1745 is based on de novo generation results of Insilico’s Chemistry42, the generative AI platform combining more than 40 generative models. With in vivo anti-tumor activity validated in multiple cancer models, the candidate compound showed robust in vivo efficacy as monotherapy as well as combination potential with chemotherapies, targeted agents including MAT2A inhibitor, and immunotherapies. CAMBRIDGE, ...

A “ticking time bomb” for liver cancer

A “ticking time bomb” for liver cancer
2025-01-02
Scientists at University of California San Diego School of Medicine have shed new light on the development of liver cancer, the sixth most frequently diagnosed cancer and fourth leading cause of cancer deaths worldwide. The study, published in Nature, reveals a complex interplay between cellular metabolism and DNA damage that drives the progression of fatty liver disease to cancer. The findings suggest new paths forward for preventing and treating liver cancer and have significant implications on our understanding of cancer’s origin and the effects of diet on our DNA. The incidence of the most common form of liver cancer, hepatocellular carcinoma (HCC), has grown by 25-30% in the past ...

LAST 30 PRESS RELEASES:

Slowed by sound: A mouse model of Parkinson’s Disease shows noise affects movement

Demographic shifts could boost drug-resistant infections across Europe

Insight into how sugars regulate the inflammatory disease process

PKU scientists uncover climate impacts and future trends of hailstorms in China

Computer model mimics human audiovisual perception

AC instead of DC: A game-changer for VR headsets and near-eye displays

Prevention of cardiovascular disease events and deaths among black adults via systolic blood pressure equity

Facility-based uptake of colorectal cancer screening in 45- to 49-year-olds after US guideline changes

Scientists uncover hidden nuclear droplets that link multiple leukemias and reveal a new therapeutic target

A new patch could help to heal the heart

New study shows people with spinal cord injuries are more likely to develop chronic disorders

Heat as a turbo-boost for immune cells

Jülich researchers reveal: Long-lived contrails usually form in natural ice clouds

Controlling next-generation energy conversion materials with simple pressure

More than 100,000 Norwegians suffer from work-related anxiety

The American Pediatric Society selects Dr. Harolyn Belcher as the recipient of the 2026 David G. Nichols Health Equity Award

Taft Armandroff and Brian Schmidt elected to lead Giant Magellan Telescope Board of Directors

FAU Engineering receives $1.5m gift to launch the ‘Ubicquia Innovation Center for Intelligent Infrastructure’

Japanese public show major reservations to cell donation for human brain organoid research

NCCN celebrates expanding access to cancer treatment in Africa at 2025 AORTIC Meeting with new NCCN adaptations for Sub-Saharan Africa

Three health tech innovators recognized for digital solutions to transform cardiovascular care

A sequence of human rights violations precedes mass atrocities, new research shows

Genetic basis of spring-loaded spider webs

Seeing persuasion in the brain

Allen Institute announces 2025 Next Generation Leaders

Digital divide narrows but gaps remain for Australians as GenAI use surges

Advanced molecular dynamics simulations capture RNA folding with high accuracy

Chinese Neurosurgical Journal Study unveils absorbable skull device that speeds healing

Heatwave predictions months in advance with machine learning: A new study delivers improved accuracy and efficiency

2.75-million-year-old stone tools may mark a turning point in human evolution

[Press-News.org] Knowledge and worry following review of standard vs patient-centered pathology reports
JAMA